Towa Pharmaceutical Co., Ltd. (TWAPF)
25.98
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Towa Pharmaceutical Debt to Equity Ratio : 1.26 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.26 |
| March 31, 2026 | 1.273 |
| December 31, 2025 | 1.232 |
| September 30, 2025 | 1.314 |
| June 30, 2025 | 1.377 |
| March 31, 2025 | 1.346 |
| December 31, 2024 | 1.322 |
| September 30, 2024 | 1.386 |
| June 30, 2024 | 1.308 |
| March 31, 2024 | 1.298 |
| December 31, 2023 | 1.318 |
| September 30, 2023 | 1.255 |
| June 30, 2023 | 1.257 |
| March 31, 2023 | 1.180 |
| December 31, 2022 | 1.062 |
| September 30, 2022 | 1.075 |
| June 30, 2022 | 1.180 |
| March 31, 2022 | 1.065 |
| December 31, 2021 | 0.5841 |
| September 30, 2021 | 0.6303 |
| June 30, 2021 | 0.6638 |
| March 31, 2021 | 0.7066 |
| December 31, 2020 | 0.7539 |
| September 30, 2020 | 0.7842 |
| June 30, 2020 | 0.9279 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.7624 |
| December 31, 2019 | 0.6111 |
| September 30, 2019 | 0.6404 |
| June 30, 2019 | 0.6843 |
| March 31, 2019 | 0.7158 |
| December 31, 2018 | 0.7007 |
| September 30, 2018 | 0.74 |
| June 30, 2018 | 0.7787 |
| March 31, 2018 | 0.8127 |
| December 31, 2017 | 0.8234 |
| September 30, 2017 | 0.8449 |
| June 30, 2017 | 0.7652 |
| March 31, 2017 | 0.7836 |
| December 31, 2016 | 0.7991 |
| September 30, 2016 | 0.8474 |
| June 30, 2016 | 0.8308 |
| March 31, 2016 | 0.8112 |
| December 31, 2015 | 0.7022 |
| September 30, 2015 | 0.7192 |
| June 30, 2015 | 0.4501 |
| March 31, 2015 | 0.3207 |
| December 31, 2014 | 0.3481 |
| September 30, 2014 | 0.3116 |
| June 30, 2014 | 0.3416 |
| March 31, 2014 | 0.3483 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.6536 |
| Daiichi Sankyo Co., Ltd. | 0.2939 |
| Eisai Co., Ltd. | 0.2993 |
| Chugai Pharmaceutical Co., Ltd. | 0.0087 |
| Santen Pharmaceutical Co., Ltd. | 0.1033 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.958B |
| Total Liabilities (Quarterly) | 1.835B |
| Shareholders Equity (Quarterly) | 1.123B |
| Current Ratio | 2.821 |
| Net Debt Paydown Yield | 2.08% |